Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
6(43%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_3
2
14%
Ph not_applicable
2
14%
Ph phase_1
2
14%
Ph phase_4
3
21%
Ph phase_2
5
36%

Phase Distribution

2

Early Stage

5

Mid Stage

5

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
2(14.3%)
Phase 2Efficacy & side effects
5(35.7%)
Phase 3Large-scale testing
2(14.3%)
Phase 4Post-market surveillance
3(21.4%)
N/ANon-phased studies
2(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

6

trials recruiting

Total Trials

14

all time

Status Distribution
Active(6)
Completed(6)
Terminated(2)

Detailed Status

Completed6
Recruiting6
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
6
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (14.3%)
Phase 25 (35.7%)
Phase 32 (14.3%)
Phase 43 (21.4%)
N/A2 (14.3%)

Trials by Status

withdrawn17%
terminated17%
completed643%
recruiting643%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT06358313Phase 3

Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke

Recruiting
NCT06248671Phase 2

Prophylactic Treatment With Atorvastatin for Episodic Migraine.

Recruiting
NCT06199921Phase 2

ATORvastatin in Pulmonary TUBerculosis

Recruiting
NCT06485336Phase 2

Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)

Recruiting
NCT06784557Phase 4

Effect of Ezetimibe on Gut Microbiota

Recruiting
NCT04147286Phase 2

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion

Recruiting
NCT05895123Phase 2

Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients

Completed
NCT04333407Not Applicable

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

Terminated
NCT03188978Phase 1

High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study

Withdrawn
NCT03874156Phase 4

MUscle Side-Effects of Atorvastatin in Coronary Patients

Completed
NCT03338426Phase 3

A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia

Completed
NCT02155530Not Applicable

COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial

Completed
NCT01856374Phase 4

Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study

Completed
NCT01842256Phase 1

Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14